Molecular Biology journals by time to acceptance (2025)
389 journals with 2025 figures · median days from submission to acceptance, measured from PubMed dates · data as of Sep 15, 2026
Sorted by median days from submission to acceptance in 2025. Faster is not better — this is a planning aid, not a ranking of quality. Click a column to re-sort.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Doklady Biochemistry and Biophysics | 17 (13–26) | 90 | 94 | — | — | 0.0 |
| Genes | 29 (22–38) | 1,505 | 3 | ≈$3,137 | Open access | 0.21 |
| Current Issues in Molecular Biology | 34 (26–43) | 1,070 | 3 | ≈$2,689 | Open access (DOAJ) | 0.33 |
| Metabolites | 36 (28–48) | 817 | 4 | ≈$3,300 | Open access (DOAJ) | 0.0 |
| The Plant Cell | 37 (9–99) | 285 | — | ≈$4,934 | Hybrid | 0.0 |
| International Journal of Molecular Sciences | 38 (29–50) | 11,991 | 3 | ≈$3,499 | Open access | 0.14 |
| Cells | 39 (29–53) | 2,035 | 3 | ≈$3,300 | Open access (DOAJ) | 0.07 |
| Biomolecules | 41 (31–54) | 1,761 | 3 | ≈$3,300 | Open access (DOAJ) | 0.11 |
| Redox Biology | 41 (25–67) | 483 | 2 | $4,700 | Open access (DOAJ) | 1.51 |
| BioTech | 45 (35–57) | 100 | 3 | ≈$1,956 | Open access (DOAJ) | 0.0 |
| Trends in Pharmacological Sciences | 50 (27–78) | 120 | 25 | ≈$7,030 | Hybrid | 0.0 |
| Methods and Protocols | 51 (42–65) | 157 | 5 | ≈$2,200 | Open access (DOAJ) | 0.0 |
| Epigenomes | 52 (38–69) | 52 | 3 | ≈$1,833 | Open access (DOAJ) | — |
| Bioscience Biotechnology and Biochemistry | 53 (37–77) | 207 | — | ≈$3,272 | — | 0.89 |
| The Journal of Microbiology | 54 (36–81) | 96 | 60 | ≈$3,690 | — | 0.0 |
| Plant Cell Reports | 56 (39–87) | 275 | 16 | ≈$4,590 | — | 0.0 |
| Current Opinion in Biotechnology | 56 (28–92) | 114 | 22 | ≈$4,530 | Hybrid | 0.0 |
| Journal of Microbiology and Biotechnology | 57 (36–82) | 298 | 39 | — | — | 0.0 |
| ACS Medicinal Chemistry Letters | 57 (40–84) | 264 | 6 | ≈$4,500 | Hybrid | 0.0 |
| Biochemical and Biophysical Research Communications | 59 (8–90) | 1,484 | 1 | ≈$3,110 | Hybrid | 0.15 |
| Trends in Genetics | 59 (38–83) | 102 | 27 | ≈$7,030 | Hybrid | 0.0 |
| European Journal of Medicinal Chemistry | 61 (46–80) | 1,076 | 3 | ≈$4,650 | Hybrid | 0.0 |
| Bioorganic & Medicinal Chemistry | 61 (47–78) | 339 | 2 | ≈$3,960 | — | 0.0 |
| Stem Cell Reviews and Reports | 61 (43–103) | 80 | 17 | ≈$4,390 | — | 0.0 |
| Proteomes | 61 (46–87) | 68 | 6 | ≈$2,200 | Open access (DOAJ) | 0.0 |
| Frontiers in Molecular Biosciences | 62 (41–94) | 478 | 20 | ≈$3,850 | Open access (DOAJ) | 2.08 |
| Archives of Microbiology | 62 (44–88) | 476 | 19 | ≈$4,090 | Hybrid | 0.82 |
| Biology Open | 62 (22–127) | 152 | 34 | $2,500 | Open access (DOAJ) | 0.0 |
| Non-Coding RNA | 62 (49–81) | 77 | 4 | ≈$2,200 | Open access (DOAJ) | 0.0 |
| The Journal of Biochemistry | 63 (34–94) | 79 | — | ≈$3,276 | — | 0.0 |
| iMeta | 63 (43–97) | 66 | 20 | $4,960 | Open access (DOAJ) | 0.0 |
| BIO-PROTOCOL | 64 (53–81) | 375 | 36 | $1,200 | Open access (DOAJ) | 0.52 |
| Protein Expression and Purification | 64 (48–80) | 136 | 1 | ≈$3,680 | — | 0.0 |
| Free Radical Biology and Medicine | 65 (47–98) | 635 | 1 | ≈$4,240 | Hybrid | 0.0 |
| Journal of Peptide Science | 66 (42–104) | 73 | — | ≈$4,030 | — | 0.0 |
| Genes to Cells | 67 (38–124) | 75 | — | ≈$3,800 | — | 0.0 |
| Biophysical Reviews | 68 (46–91) | 113 | 16 | ≈$3,990 | — | 0.0 |
| Function | 68 (38–97) | 51 | — | $3,900 | Open access (DOAJ) | 0.0 |
| Frontiers in Cell and Developmental Biology | 69 (47–99) | 1,074 | 18 | ≈$3,850 | Open access (DOAJ) | 2.23 |
| Acta Crystallographica Section F Structural Biology Communications | 69 (51–100) | 64 | 16 | ≈$3,520 | — | 0.0 |
| Iranian Journal of Biotechnology | 70 (38–146) | 57 | 94 | — | Open access | 0.0 |
| IET Systems Biology | 70 (50–93) | 56 | — | $2,400 | Open access (DOAJ) | — |
| Genetics | 71 (42–116) | 256 | — | ≈$4,477 | Hybrid | 0.0 |
| Combinatorial Chemistry & High Throughput Screening | 71 (54–94) | 192 | 136 | — | — | 0.0 |
| Current Opinion in Microbiology | 71 (50–107) | 69 | 21 | ≈$3,800 | Hybrid | 0.0 |
| Genes Chromosomes and Cancer | 71 (44–109) | 68 | — | ≈$4,810 | — | 0.0 |
| Bioorganic Chemistry | 73 (52–104) | 1,192 | 2 | ≈$4,240 | Hybrid | 0.23 |
| G3 Genes Genomes Genetics | 73 (47–113) | 307 | — | $2,580 | Open access (DOAJ) | 0.0 |
| Bioorganic & Medicinal Chemistry Letters | 73 (54–104) | 304 | 2 | ≈$3,880 | Hybrid | 0.57 |
| Natural Products and Bioprospecting | 73 (49–99) | 90 | 43 | $2,590 | Open access (DOAJ) | 0.0 |
| Biomedicine & Pharmacotherapy | 74 (57–97) | 998 | 6 | ≈$3,610 | Open access | 2.37 |
| Frontiers in Bioscience-Landmark | 74 (59–91) | 328 | — | $2,500 | Open access (DOAJ) | 0.0 |
| Trends in Biochemical Sciences | 74 (15–95) | 121 | 28 | ≈$7,030 | — | 0.0 |
| Frontiers in Bioinformatics | 75 (57–111) | 175 | 24 | ≈$3,117 | Open access (DOAJ) | 0.0 |
| Mammalian Genome | 75 (50–104) | 86 | 17 | ≈$3,890 | — | 22.51 |
| Journal of Plant Physiology | 76 (55–115) | 162 | 1 | ≈$3,370 | — | 0.0 |
| SLAS DISCOVERY | 76 (55–117) | 74 | 1 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| Protein & Cell | 76 (45–141) | 68 | — | $2,570 | Open access (DOAJ) | 0.0 |
| Molecular Biology Reports | 77 (57–111) | 1,169 | 11 | ≈$4,290 | Hybrid | 1.74 |
| Synthetic and Systems Biotechnology | 77 (58–92) | 176 | 4 | $1,500 | Open access (DOAJ) | 0.0 |
| AMB Express | 77 (56–120) | 173 | 23 | $3,090 | Open access (DOAJ) | 1.25 |
| Biology Direct | 77 (45–115) | 127 | 16 | $2,990 | Open access (DOAJ) | 0.0 |
| Biophysical Chemistry | 77 (56–107) | 92 | 2 | ≈$3,720 | — | 0.0 |
| Genes & Genomics | 78 (41–108) | 115 | 25 | ≈$2,390 | — | 1.51 |
| Frontiers in Pharmacology | 79 (53–120) | 3,916 | 19 | ≈$3,850 | Open access (DOAJ) | 0.66 |
| Neoplasia | 79 (43–117) | 133 | 8 | $3,790 | Open access (DOAJ) | 1.88 |
| In Vitro Cellular & Developmental Biology - Animal | 79 (53–121) | 130 | 58 | ≈$2,490 | — | 0.0 |
| Biology Methods and Protocols | 79 (44–110) | 90 | 3 | $1,067 | Open access (DOAJ) | 0.0 |
| Molecules and Cells | 79 (63–108) | 63 | 5 | $2,500 | Open access (DOAJ) | 0.0 |
| Data in Brief | 80 (50–127) | 1,145 | 7 | $1,330 | Open access (DOAJ) | 0.0 |
| RSC Chemical Biology | 80 (53–110) | 167 | 3 | ≈$2,831 | Open access (DOAJ) | 0.0 |
| Methods | 81 (56–115) | 157 | 2 | ≈$3,600 | — | 0.0 |
| Biomolecules & Therapeutics | 81 (43–109) | 81 | 33 | — | — | 0.0 |
| Glycobiology | 81 (50–138) | 75 | — | ≈$4,756 | Hybrid | 0.0 |
| Analytical Biochemistry | 82 (55–116) | 188 | 1 | ≈$3,540 | Hybrid | 0.0 |
| Trends in Plant Science | 82 (48–136) | 185 | 24 | ≈$7,030 | Hybrid | 0.0 |
| FEBS Letters | 83 (55–116) | 265 | 32 | ≈$3,980 | Hybrid | 0.91 |
| BioData Mining | 83 (58–151) | 89 | 17 | $2,790 | Open access (DOAJ) | 0.0 |
| Biosensors and Bioelectronics | 84 (61–119) | 1,023 | 1 | ≈$5,540 | Hybrid | 0.23 |
| Computational Biology and Chemistry | 84 (59–120) | 462 | 4 | ≈$3,320 | — | 0.0 |
| Functional & Integrative Genomics | 84 (61–117) | 280 | 20 | ≈$2,690 | — | 24.92 |
| Photochemistry and Photobiology | 84 (58–129) | 128 | 21 | ≈$4,330 | — | 0.0 |
| Journal of Natural Medicines | 84 (53–114) | 119 | 28 | ≈$4,590 | — | 0.0 |
| Current Opinion in Plant Biology | 84 (62–120) | 105 | 25 | ≈$4,810 | Hybrid | 0.0 |
| IUBMB Life | 84 (59–146) | 77 | — | ≈$4,430 | Hybrid | 0.0 |
| Biotechnology for Biofuels and Bioproducts | 85 (66–118) | 128 | 20 | $2,990 | Open access (DOAJ) | 0.0 |
| Journal of Human Genetics | 85 (48–131) | 127 | 15 | ≈$5,490 | — | 0.0 |
| Biosystems | 86 (56–133) | 187 | 3 | ≈$2,870 | Hybrid | 0.0 |
| Journal of Molecular Biology | 87 (58–121) | 409 | 4 | ≈$4,730 | Hybrid | 0.0 |
| ACS Bio & Med Chem Au | 87 (73–110) | 64 | 12 | $3,500 | Open access (DOAJ) | 0.0 |
| TURKISH JOURNAL OF BIOLOGY | 87 (65–110) | 54 | 0 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| Photosynthesis Research | 87 (63–121) | 54 | 12 | ≈$3,890 | — | 2.89 |
| Frontiers in Genetics | 88 (60–132) | 880 | 20 | ≈$3,850 | Open access (DOAJ) | 1.31 |
| Fitoterapia | 88 (66–118) | 604 | 2 | ≈$3,950 | — | 0.0 |
| Molecular Cancer | 88 (57–131) | 301 | 29 | $5,290 | Open access (DOAJ) | 0.0 |
| PLANT PHYSIOLOGY | 90 (30–146) | 670 | — | ≈$3,851 | Hybrid | 0.32 |
| Current Pharmaceutical Biotechnology | 90 (64–110) | 141 | 127 | — | — | 0.0 |
| Computational and Structural Biotechnology Journal | 91 (67–116) | 556 | 3 | ≈$3,404 | Open access (DOAJ) | 0.0 |
| ACS Pharmacology & Translational Science | 91 (63–129) | 289 | 10 | ≈$4,500 | Hybrid | 0.0 |
| Stem Cell Research | 91 (52–151) | 246 | 2 | $2,460 | Open access (DOAJ) | 0.59 |
| Human Genomics | 91 (57–152) | 174 | 23 | $3,390 | Open access (DOAJ) | 0.0 |
| Current Opinion in Structural Biology | 91 (69–107) | 162 | 26 | ≈$4,360 | Hybrid | 1.34 |
| Enzyme and Microbial Technology | 91 (71–123) | 153 | 2 | ≈$3,700 | — | 0.0 |
| Trends in Cell Biology | 91 (71–111) | 86 | 27 | ≈$7,030 | Hybrid | 0.0 |
| Protein and Peptide Letters | 91 (78–109) | 68 | — | — | — | 0.0 |
| Cancer Letters | 92 (67–128) | 511 | 1 | ≈$4,960 | Hybrid | 0.96 |
| Cell Proliferation | 92 (67–135) | 138 | 16 | $3,680 | Open access (DOAJ) | 0.0 |
| Science China Life Sciences | 93 (55–136) | 306 | 81 | ≈$3,790 | — | 0.0 |
| Drug Discovery Today | 93 (66–146) | 264 | 4 | ≈$4,720 | — | 0.0 |
| Probiotics and Antimicrobial Proteins | 93 (70–140) | 194 | 15 | ≈$4,090 | Hybrid | 0.0 |
| Bioprocess and Biosystems Engineering | 93 (66–128) | 154 | 16 | ≈$4,090 | — | 2.59 |
| Food Chemistry Molecular Sciences | 93 (76–126) | 113 | 2 | $2,730 | Open access (DOAJ) | 0.0 |
| Journal of Bioscience and Bioengineering | 93 (70–126) | 111 | 24 | ≈$3,000 | — | 0.0 |
| Biological Procedures Online | 93 (54–125) | 62 | 29 | $3,590 | Open access (DOAJ) | — |
| Plant Physiology and Biochemistry | 94 (65–138) | 1,367 | 1 | ≈$3,990 | Hybrid | 0.75 |
| STAR Protocols | 94 (71–122) | 720 | 22 | $1,920 | Open access (DOAJ) | 0.0 |
| Cellular Signalling | 94 (68–130) | 641 | 2 | ≈$3,550 | Hybrid | 2.1 |
| Bioresources and Bioprocessing | 94 (77–124) | 162 | 23 | $1,990 | Open access (DOAJ) | 1.63 |
| Journal of Biological Engineering | 94 (63–136) | 139 | 17 | $3,090 | Open access (DOAJ) | 0.0 |
| RNA | 94 (45–141) | 118 | 74 | — | Hybrid | 1.59 |
| Current Opinion in Cell Biology | 94 (68–122) | 100 | 25 | ≈$4,390 | Hybrid | 0.0 |
| Neurogenetics | 94 (64–147) | 75 | 15 | ≈$4,590 | — | 4.48 |
| Cell Calcium | 94 (67–150) | 51 | 1 | ≈$3,950 | — | 0.0 |
| Journal of Molecular Histology | 95 (59–143) | 350 | 25 | ≈$3,890 | — | 1.41 |
| Microbial Cell Factories | 95 (69–144) | 270 | 18 | $3,690 | Open access (DOAJ) | 1.46 |
| Mini-Reviews in Medicinal Chemistry | 95 (76–110) | 151 | — | — | — | 0.0 |
| Neuromuscular Disorders | 95 (69–131) | 104 | 1 | ≈$3,470 | — | 1.75 |
| Current Protein and Peptide Science | 95 (75–116) | 82 | 138 | — | — | 0.0 |
| Biopolymers | 95 (49–125) | 81 | — | ≈$4,150 | — | 0.0 |
| Acta Crystallographica Section D Structural Biology | 95 (75–155) | 61 | 20 | ≈$5,230 | Hybrid | 0.0 |
| Journal of genetics and genomics/Journal of Genetics and Genomics | 96 (66–130) | 126 | 7 | ≈$3,140 | — | 0.0 |
| Cancer Drug Resistance | 96 (69–117) | 63 | 12 | — | Open access | 0.0 |
| The Journal of Gene Medicine | 96 (71–139) | 59 | — | ≈$4,480 | — | 2.26 |
| Fungal Genetics and Biology | 96 (74–125) | 54 | 5 | ≈$3,210 | — | 0.0 |
| Gene | 97 (70–133) | 475 | 2 | ≈$3,300 | — | 0.0 |
| Journal of Integrative Plant Biology | 97 (50–173) | 264 | 30 | ≈$3,000 | — | 0.0 |
| Journal of Cancer | 97 (73–133) | 246 | 21 | ≈$2,850 | Open access (DOAJ) | 0.92 |
| Frontiers in Microbiomes | 97 (64–150) | 59 | 23 | ≈$2,383 | Open access (DOAJ) | — |
| General Physiology and Biophysics | 97 (74–141) | 53 | — | — | Open access | 0.0 |
| Biotechnology Journal | 98 (70–128) | 190 | — | ≈$4,780 | — | 0.0 |
| DNA repair | 98 (66–133) | 92 | 3 | ≈$3,390 | Hybrid | 2.07 |
| International Journal of Oncology | 98 (74–133) | 86 | 34 | — | Hybrid | 3.6 |
| Current Opinion in Genetics & Development | 98 (74–131) | 75 | 22 | ≈$4,200 | Hybrid | 0.0 |
| Current Gene Therapy | 98 (71–124) | 71 | 124 | — | — | 0.0 |
| Archives of Biochemistry and Biophysics | 99 (61–144) | 314 | 1 | ≈$3,170 | Hybrid | 2.33 |
| Microbial Biotechnology | 99 (61–152) | 196 | — | $4,260 | Open access (DOAJ) | 0.0 |
| Current Molecular Medicine | 99 (76–126) | 116 | 145 | — | — | 0.0 |
| Trends in Molecular Medicine | 99 (56–141) | 111 | 25 | ≈$7,030 | Hybrid | 0.0 |
| Extracellular Vesicles and Circulating Nucleic Acids | 99 (81–129) | 72 | 19 | — | — | — |
| Cytotechnology | 100 (61–148) | 174 | 14 | ≈$4,190 | — | 2.39 |
| Journal of Structural Biology | 100 (70–154) | 84 | 2 | ≈$4,350 | Hybrid | 0.0 |
| Theranostics | 101 (64–128) | 566 | 24 | ≈$3,206 | Open access (DOAJ) | 0.0 |
| Journal of Experimental & Clinical Cancer Research | 101 (73–131) | 327 | 17 | $4,490 | Open access (DOAJ) | 5.19 |
| APOPTOSIS | 101 (72–147) | 82 | 27 | ≈$5,090 | Hybrid | 1.95 |
| Planta | 102 (66–151) | 302 | 14 | ≈$4,590 | Hybrid | 1.5 |
| Biochimie | 102 (68–155) | 170 | 1 | ≈$3,110 | Hybrid | 0.0 |
| Pflügers Archiv - European Journal of Physiology | 102 (66–146) | 74 | 18 | ≈$4,390 | — | 0.0 |
| Journal of Computer-Aided Molecular Design | 103 (80–135) | 174 | 20 | ≈$4,190 | — | 0.0 |
| BMC Biotechnology | 103 (71–156) | 148 | 18 | $3,090 | Open access (DOAJ) | 0.0 |
| Journal of Cell Communication and Signaling | 103 (70–173) | 54 | 23 | ≈$2,860 | — | 0.0 |
| BMC Plant Biology | 104 (72–161) | 1,992 | 21 | $3,190 | Open access (DOAJ) | 0.0 |
| International Journal of Molecular Medicine | 104 (80–131) | 219 | 32 | — | Hybrid | 12.55 |
| Journal of Genetic Engineering and Biotechnology | 104 (70–170) | 191 | 13 | $1,000 | Open access (DOAJ) | 0.0 |
| Human Molecular Genetics | 104 (71–152) | 177 | — | ≈$4,390 | Hybrid | 0.0 |
| Biofilm | 104 (78–144) | 85 | 1 | $3,200 | Open access (DOAJ) | 0.0 |
| Biochemical Pharmacology | 105 (82–136) | 753 | 1 | ≈$3,590 | Hybrid | 0.4 |
| Biochemistry and Biophysics Reports | 105 (74–154) | 514 | 6 | $2,750 | Open access (DOAJ) | 0.0 |
| Plant Science | 105 (76–143) | 476 | 2 | ≈$3,760 | — | 0.0 |
| Molecular Plant | 105 (30–179) | 223 | 3 | ≈$5,000 | Hybrid | 0.0 |
| Metabolic Engineering | 105 (80–135) | 144 | 1 | ≈$4,780 | Hybrid | 0.0 |
| Molecular Carcinogenesis | 105 (70–143) | 127 | 19 | ≈$4,490 | — | 0.0 |
| FEMS Yeast Research | 105 (72–163) | 72 | — | ≈$3,371 | Open access (DOAJ) | 0.0 |
| Biotechnology and Bioengineering | 106 (79–140) | 262 | 13 | ≈$5,060 | — | 0.0 |
| Phytochemical Analysis | 106 (72–138) | 85 | 13 | ≈$4,380 | — | 0.0 |
| Current Medicinal Chemistry | 107 (79–142) | 402 | 146 | — | — | 0.0 |
| Applied Microbiology and Biotechnology | 107 (75–153) | 290 | 21 | $4,390 | Open access (DOAJ) | 0.39 |
| Biochemical Journal | 107 (69–149) | 115 | 19 | — | — | 0.0 |
| International Journal of Genomics | 107 (71–173) | 96 | 34 | $2,620 | Open access (DOAJ) | 0.0 |
| Experimental Cell Research | 108 (75–154) | 299 | 2 | ≈$3,270 | — | 0.68 |
| Molecular and Cellular Biochemistry | 109 (81–152) | 250 | 15 | ≈$4,190 | — | 7.44 |
| Journal of Biotechnology | 109 (85–143) | 221 | 2 | ≈$4,360 | — | 0.0 |
| Journal of Inherited Metabolic Disease | 109 (78–150) | 130 | — | ≈$3,470 | — | 0.0 |
| Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 109 (78–147) | 115 | 2 | ≈$3,670 | Hybrid | 0.0 |
| Experimental Eye Research | 110 (78–159) | 462 | 1 | ≈$4,010 | Hybrid | 0.57 |
| Antonie van Leeuwenhoek | 110 (75–146) | 179 | 16 | ≈$3,690 | — | 0.0 |
| Journal of Eukaryotic Microbiology | 110 (66–158) | 54 | — | ≈$3,090 | — | 0.0 |
| Cell Communication and Signaling | 111 (79–150) | 609 | 17 | $3,490 | Open access (DOAJ) | 0.0 |
| Chinese Medicine | 111 (80–148) | 255 | 24 | $3,090 | Open access (DOAJ) | 0.0 |
| Oncology Reports | 111 (91–142) | 132 | 38 | — | Hybrid | 11.26 |
| World Journal of Stem Cells | 111 (88–142) | 124 | — | — | Hybrid | 0.0 |
| PROTOPLASMA | 111 (72–151) | 115 | 14 | ≈$3,690 | — | 0.0 |
| Systematic and Applied Microbiology | 111 (70–150) | 57 | 2 | ≈$4,010 | — | 0.0 |
| Journal of Biological Chemistry | 112 (70–163) | 1,252 | 7 | $3,430 | Open access (DOAJ) | 0.0 |
| Non-coding RNA Research | 112 (84–152) | 93 | 2 | $1,100 | Open access (DOAJ) | 0.0 |
| Advanced Drug Delivery Reviews | 113 (84–160) | 131 | 3 | ≈$5,550 | — | 0.0 |
| Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics | 113 (85–141) | 57 | 1 | ≈$3,900 | — | 0.0 |
| The FASEB Journal | 114 (87–152) | 1,048 | — | ≈$3,740 | Hybrid | 1.36 |
| Biotechnology Reports | 114 (81–152) | 67 | 1 | $3,630 | Open access (DOAJ) | 0.0 |
| International Journal of Biological Sciences | 115 (84–157) | 398 | 22 | ≈$1,425 | Open access (DOAJ) | 0.56 |
| Protein Science | 116 (89–153) | 416 | — | ≈$4,480 | Hybrid | 0.66 |
| Clinical and Translational Medicine | 116 (85–152) | 313 | — | $3,640 | Open access (DOAJ) | 1.59 |
| Genes & Development | 116 (80–154) | 87 | 129 | — | Open access | 0.0 |
| Mobile DNA | 116 (73–145) | 51 | 21 | $3,190 | Open access (DOAJ) | — |
| Plant Biotechnology Journal | 117 (80–176) | 571 | 20 | $4,750 | Open access (DOAJ) | 0.0 |
| Trends in biotechnology | 117 (74–179) | 273 | 29 | ≈$7,030 | — | 0.0 |
| Cellular Oncology | 117 (90–149) | 105 | 34 | $2,380 | Open access (DOAJ) | 1.88 |
| BMC Genomic Data | 117 (85–167) | 104 | 21 | $2,290 | Open access (DOAJ) | 0.0 |
| Briefings in Bioinformatics | 118 (87–155) | 738 | — | $3,885 | Open access (DOAJ) | 0.0 |
| Phytomedicine | 119 (88–160) | 1,365 | 2 | ≈$3,630 | — | 0.24 |
| Folia Microbiologica | 119 (60–166) | 178 | 19 | ≈$2,590 | Hybrid | 0.0 |
| Cancer Science | 120 (83–148) | 276 | 15 | $2,600 | Open access (DOAJ) | 1.74 |
| Cell & Bioscience | 120 (93–161) | 179 | 19 | $2,990 | Open access (DOAJ) | 1.05 |
| FEBS Open Bio | 120 (83–160) | 178 | 14 | $2,480 | Open access (DOAJ) | 5.47 |
| Acta Botanica Yunnanica | 120 (91–160) | 95 | 6 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| Horticulture Research | 121 (97–156) | 328 | 10 | $2,960 | Open access (DOAJ) | 0.66 |
| Epigenetics & Chromatin | 121 (96–161) | 88 | 19 | $3,290 | Open access (DOAJ) | 0.0 |
| Carcinogenesis | 121 (88–183) | 82 | — | ≈$4,835 | — | 2.21 |
| Biochimica et Biophysica Acta (BBA) - Biomembranes | 121 (82–166) | 71 | 3 | ≈$3,870 | Hybrid | 0.0 |
| aBIOTECH | 121 (88–135) | 55 | 21 | ≈$2,190 | — | — |
| European Journal of Pharmacology | 122 (90–162) | 1,009 | 1 | ≈$3,230 | — | 0.0 |
| Biological Research | 122 (82–220) | 78 | 20 | $2,890 | Open access (DOAJ) | 0.0 |
| European Biophysics Journal | 122 (81–178) | 71 | 24 | ≈$2,490 | — | 0.0 |
| Biochimica et Biophysica Acta (BBA) - General Subjects | 123 (86–165) | 133 | 3 | ≈$3,310 | Hybrid | 0.0 |
| Human Mutation | 123 (73–189) | 119 | 35 | ≈$2,740 | Hybrid | 0.0 |
| Acta Pharmacologica Sinica | 124 (97–153) | 252 | 37 | ≈$4,390 | Hybrid | 0.0 |
| Oncology Letters | 125 (98–155) | 508 | 33 | — | Open access | 6.38 |
| Biomedical Reports | 125 (98–166) | 175 | 27 | — | Open access | 0.0 |
| Proteins Structure Function and Bioinformatics | 125 (92–168) | 159 | 14 | ≈$4,550 | — | 0.0 |
| BioEssays | 125 (75–158) | 103 | 14 | ≈$5,330 | — | 0.0 |
| Bioinformatics Advances | 126 (91–161) | 325 | 4 | $2,620 | Open access (DOAJ) | 0.0 |
| Plant and Cell Physiology | 126 (90–185) | 171 | — | ≈$3,085 | Hybrid | 1.26 |
| Cell Biology International | 126 (90–193) | 129 | 15 | ≈$3,730 | — | 2.58 |
| Biophysical Journal | 127 (92–170) | 429 | 3 | ≈$3,000 | Hybrid | 0.0 |
| Forensic Science International Genetics | 127 (90–170) | 131 | 2 | ≈$5,020 | — | 0.0 |
| Molecular Pharmacology | 127 (95–160) | 74 | 7 | ≈$3,600 | Hybrid | 0.0 |
| Molecular Biotechnology | 128 (88–191) | 171 | 26 | ≈$3,790 | — | 0.0 |
| Molecular Microbiology | 128 (91–183) | 74 | 15 | ≈$4,430 | Hybrid | 0.0 |
| Biotechnology Advances | 129 (92–162) | 215 | 2 | ≈$5,460 | — | 0.0 |
| Mitochondrion | 129 (95–173) | 61 | 2 | ≈$3,220 | — | 0.0 |
| Clinical Epigenetics | 130 (85–190) | 233 | 25 | $3,890 | Open access (DOAJ) | 0.99 |
| BMC Medical Genomics | 130 (91–242) | 214 | 22 | $3,290 | Open access (DOAJ) | 1.43 |
| Cell Biology and Toxicology | 130 (100–161) | 144 | 25 | ≈$4,190 | — | 0.0 |
| Cellular and Molecular Life Sciences | 131 (91–189) | 479 | 37 | $4,390 | Open access (DOAJ) | 0.0 |
| Biochimica et Biophysica Acta (BBA) - Reviews on Cancer | 131 (99–161) | 262 | 3 | ≈$5,070 | — | 0.0 |
| Journal of Cheminformatics | 132 (103–171) | 188 | 25 | $2,390 | Open access (DOAJ) | 0.0 |
| Journal of Neurochemistry | 133 (82–183) | 307 | — | ≈$5,330 | — | 0.0 |
| Molecular Medicine Reports | 133 (105–163) | 306 | 38 | — | Hybrid | 10.8 |
| Developmental Biology | 133 (84–206) | 226 | 2 | ≈$3,550 | Hybrid | 0.0 |
| Experimental and Therapeutic Medicine | 133 (102–168) | 219 | 35 | — | Open access | 5.55 |
| FEMS Microbiology Reviews | 133 (85–179) | 66 | — | ≈$3,371 | Open access (DOAJ) | 0.0 |
| BMC Genomics | 134 (95–198) | 1,282 | 22 | $3,190 | Open access (DOAJ) | 0.0 |
| Open Life Sciences | 134 (96–172) | 197 | 65 | ≈$2,423 | Open access (DOAJ) | 2.91 |
| Human Cell | 134 (83–189) | 160 | 15 | ≈$2,490 | — | 5.13 |
| The International Journal of Biochemistry & Cell Biology | 134 (96–180) | 75 | 2 | ≈$3,840 | — | 2.05 |
| BioFactors | 134 (97–177) | 68 | — | ≈$4,150 | — | 2.45 |
| Human Genetics and Genomics Advances | 135 (103–173) | 130 | 4 | $2,640 | Open access (DOAJ) | 0.0 |
| Biotechnology Progress | 136 (94–182) | 99 | 21 | ≈$4,160 | — | 2.1 |
| Stem Cells | 136 (92–193) | 77 | — | ≈$4,477 | Hybrid | 0.0 |
| Seminars in Cell and Developmental Biology | 136 (74–169) | 62 | 16 | ≈$4,670 | Hybrid | 0.0 |
| Scientific Reports | 137 (94–201) | 47,228 | 17 | $2,850 | Open access (DOAJ) | 1.64 |
| BMC Bioinformatics | 137 (93–206) | 328 | 27 | $3,090 | Open access (DOAJ) | 0.0 |
| Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 138 (105–196) | 413 | 4 | ≈$4,010 | Hybrid | 0.0 |
| Phytochemistry | 138 (112–166) | 272 | 1 | ≈$4,350 | — | 0.0 |
| Developmental Dynamics | 138 (92–192) | 78 | 26 | ≈$4,430 | — | 0.0 |
| The Plant Journal | 139 (99–194) | 640 | — | ≈$5,450 | Hybrid | 0.4 |
| Chemical Biology & Drug Design | 139 (85–223) | 191 | — | ≈$3,920 | — | 0.0 |
| New Biotechnology | 139 (102–218) | 102 | 4 | $3,180 | Open access (DOAJ) | 0.0 |
| Clinical Proteomics | 139 (80–175) | 52 | 34 | $2,690 | Open access (DOAJ) | 0.0 |
| Cell Death Discovery | 140 (107–192) | 616 | 17 | $2,790 | Open access (DOAJ) | 1.24 |
| Structure | 140 (95–206) | 189 | 25 | ≈$9,350 | Hybrid | 0.0 |
| Genomics | 141 (108–187) | 206 | 2 | $3,460 | Open access (DOAJ) | 0.85 |
| Metabolomics | 141 (89–203) | 164 | 27 | ≈$3,890 | Hybrid | 0.0 |
| PROTEOMICS | 141 (93–183) | 135 | 19 | ≈$4,650 | — | 1.39 |
| Journal of Biomedical Informatics | 142 (110–172) | 189 | 8 | ≈$3,410 | — | 0.0 |
| Journal of Ginseng Research | 142 (98–211) | 93 | 5 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| Biotechnology Letters | 143 (98–203) | 127 | 15 | ≈$3,890 | — | 1.64 |
| Molecular Genetics and Genomics | 144 (99–214) | 121 | 26 | ≈$3,990 | — | 1.8 |
| Animal Microbiome | 145 (109–190) | 134 | 27 | $2,290 | Open access (DOAJ) | 0.0 |
| Molecular Therapy | 146 (36–190) | 558 | 5 | ≈$4,500 | Hybrid | 3.26 |
| Cancer Gene Therapy | 146 (118–184) | 116 | 14 | ≈$4,990 | Hybrid | 11.08 |
| Current Biology | 147 (94–208) | 536 | 27 | ≈$7,030 | Hybrid | 0.0 |
| Biochimica et Biophysica Acta (BBA) - Molecular Cell Research | 147 (114–187) | 179 | 3 | ≈$3,930 | Hybrid | 0.0 |
| Biochemical Genetics | 148 (93–211) | 277 | 14 | ≈$4,090 | — | 1.64 |
| Journal of Molecular Evolution | 148 (117–242) | 58 | 19 | ≈$4,090 | — | 0.0 |
| Cellular & Molecular Biology Letters | 149 (113–186) | 163 | 29 | $2,990 | Open access (DOAJ) | 0.0 |
| Journal of Extracellular Biology | 149 (123–190) | 66 | 36 | $3,340 | Open access (DOAJ) | 0.0 |
| Human Genetics | 150 (92–204) | 86 | 24 | ≈$3,690 | — | 0.0 |
| The American Journal of Human Genetics | 151 (110–211) | 191 | 25 | ≈$5,150 | — | 0.0 |
| Nucleic Acids Research | 152 (79–240) | 1,496 | — | $4,192 | Open access (DOAJ) | 0.32 |
| Molecular Biology and Evolution | 152 (114–206) | 329 | — | $3,255 | Open access (DOAJ) | 0.0 |
| The Journal of Pathology | 152 (106–214) | 119 | 45 | ≈$5,450 | Hybrid | 0.0 |
| Plant Communications | 153 (106–196) | 260 | 3 | $3,500 | Open access (DOAJ) | 0.0 |
| Molecular Oncology | 153 (103–216) | 193 | 19 | $4,730 | Open access (DOAJ) | 1.02 |
| NAR Cancer | 154 (118–195) | 60 | 28 | $2,391 | Open access (DOAJ) | 0.0 |
| Journal of Cell Science | 155 (101–204) | 210 | 46 | — | Hybrid | 0.0 |
| npj Systems Biology and Applications | 155 (113–203) | 152 | 25 | $3,490 | Open access (DOAJ) | 0.0 |
| Journal of Cellular Physiology | 155 (107–190) | 93 | — | ≈$5,230 | Hybrid | 0.91 |
| Patterns | 155 (121–191) | 85 | 27 | $4,900 | Open access (DOAJ) | 0.0 |
| NAR Genomics and Bioinformatics | 156 (125–204) | 217 | 27 | $2,633 | Open access (DOAJ) | 1.26 |
| Plant Molecular Biology | 158 (102–207) | 119 | 31 | ≈$4,590 | — | 0.0 |
| Plant Direct | 158 (100–225) | 89 | 26 | $3,120 | Open access (DOAJ) | 0.0 |
| mLife | 158 (122–185) | 56 | 124 | $2,500 | Open access (DOAJ) | — |
| Molecular Therapy — Methods & Clinical Development | 159 (114–206) | 191 | 4 | $3,900 | Open access (DOAJ) | 0.0 |
| MicrobiologyOpen | 160 (112–235) | 178 | — | $3,720 | Open access (DOAJ) | 0.0 |
| PLoS Genetics | 161 (118–217) | 373 | 21 | $3,165 | Open access (DOAJ) | 0.47 |
| Experimental & Molecular Medicine | 161 (113–211) | 233 | 85 | $4,690 | Open access (DOAJ) | 0.0 |
| Journal of Cellular and Molecular Medicine | 162 (106–235) | 594 | — | $5,730 | Open access (DOAJ) | 1.66 |
| Cell Research | 162 (118–193) | 59 | 34 | ≈$5,190 | Hybrid | 0.0 |
| Journal of Molecular Cell Biology | 163 (106–219) | 62 | — | $2,730 | Open access (DOAJ) | 0.0 |
| Aging | 164 (109–267) | 140 | 21 | — | — | 2.44 |
| British Journal of Pharmacology | 165 (116–229) | 304 | 40 | ≈$4,780 | Hybrid | 0.73 |
| Life Science Alliance | 166 (117–210) | 155 | 13 | $3,500 | Open access (DOAJ) | 0.0 |
| Bioinformatics | 168 (121–229) | 619 | — | $3,798 | Open access (DOAJ) | 0.51 |
| Cancer Cell International | 168 (113–243) | 503 | 19 | $3,290 | Open access (DOAJ) | 3.52 |
| Molecular Systems Biology | 168 (104–215) | 99 | 22 | $8,270 | Open access (DOAJ) | 0.0 |
| Stem Cells Translational Medicine | 168 (121–239) | 75 | — | $2,822 | Open access (DOAJ) | 0.0 |
| Gene Therapy | 169 (134–251) | 71 | 14 | ≈$3,790 | — | 0.0 |
| Current Microbiology | 170 (119–239) | 644 | 16 | ≈$3,990 | Hybrid | 0.43 |
| npj Biofilms and Microbiomes | 171 (135–220) | 255 | 21 | $4,390 | Open access (DOAJ) | 0.0 |
| Molecular Therapy — Nucleic Acids | 171 (130–223) | 231 | 4 | $3,900 | Open access (DOAJ) | 8.36 |
| Database | 171 (129–216) | 80 | — | $2,598 | Open access (DOAJ) | 0.0 |
| EMBO Molecular Medicine | 172 (128–237) | 175 | 22 | $8,270 | Open access (DOAJ) | 1.39 |
| Development | 173 (125–224) | 244 | 39 | — | Hybrid | 0.0 |
| Journal of Theoretical Biology | 173 (130–250) | 178 | 8 | ≈$2,550 | — | 0.0 |
| Beneficial Microbes | 173 (120–257) | 52 | 21 | — | Hybrid | 0.0 |
| Molecular & Cellular Proteomics | 175 (125–238) | 212 | 3 | $4,020 | Open access (DOAJ) | 0.0 |
| GigaScience | 177 (131–221) | 152 | — | $2,638 | Open access (DOAJ) | 0.0 |
| Cell Discovery | 177 (141–215) | 67 | 50 | $3,690 | Open access (DOAJ) | 0.0 |
| Oncogenesis | 178 (130–213) | 51 | 21 | $4,390 | Open access (DOAJ) | 3.64 |
| Stem Cell Reports | 179 (118–230) | 182 | 29 | $4,400 | Open access (DOAJ) | 0.0 |
| Cell chemical biology | 179 (126–238) | 109 | 22 | ≈$9,350 | Hybrid | 0.0 |
| The Journal of General Physiology | 179 (103–293) | 53 | 27 | — | Hybrid | 0.0 |
| FEBS Journal | 180 (124–232) | 401 | 15 | ≈$5,000 | — | 0.0 |
| Biotechnology and Applied Biochemistry | 181 (110–234) | 193 | 21 | ≈$3,470 | Hybrid | 5.19 |
| iScience | 182 (133–254) | 2,505 | 4 | $3,240 | Open access (DOAJ) | 0.26 |
| Oncogene | 182 (146–226) | 315 | 14 | ≈$5,990 | Hybrid | 2.31 |
| EMBO Reports | 184 (112–248) | 289 | 21 | $8,270 | Open access (DOAJ) | 0.66 |
| BMC Biology | 186 (136–271) | 374 | 18 | $3,790 | Open access (DOAJ) | 0.0 |
| Interdisciplinary Sciences Computational Life Sciences | 187 (134–257) | 124 | 43 | ≈$3,990 | — | 0.0 |
| Microbiome | 188 (129–256) | 278 | 52 | $5,190 | Open access (DOAJ) | 0.0 |
| Archives of Pharmacal Research | 188 (130–264) | 61 | 12 | ≈$5,290 | — | 0.0 |
| Disease Models & Mechanisms | 189 (128–240) | 117 | 47 | $4,250 | Open access (DOAJ) | 0.0 |
| Journal of Extracellular Vesicles | 191 (144–243) | 170 | — | $4,850 | Open access (DOAJ) | 0.0 |
| Molecular Ecology Resources | 191 (128–283) | 148 | 16 | ≈$5,250 | — | 2.39 |
| Medicinal Research Reviews | 192 (68–275) | 52 | 18 | ≈$4,980 | — | 0.0 |
| Cell Death and Disease | 193 (153–248) | 963 | 18 | $5,250 | Open access (DOAJ) | 2.14 |
| PLoS Biology | 194 (128–261) | 431 | 28 | $5,500 | Open access (DOAJ) | 1.01 |
| Molecular Cancer Research | 195 (145–249) | 71 | — | — | — | 0.0 |
| Molecular Horticulture | 195 (143–253) | 58 | 148 | $2,600 | Open access (DOAJ) | — |
| The EMBO Journal | 196 (134–251) | 319 | 27 | $8,270 | Open access (DOAJ) | 0.7 |
| Cell Genomics | 196 (145–278) | 177 | 28 | $8,900 | Open access (DOAJ) | 0.0 |
| PLoS Computational Biology | 201 (148–267) | 798 | 23 | $3,165 | Open access (DOAJ) | 0.0 |
| Cytometry Part A | 202 (126–247) | 59 | 15 | ≈$3,970 | Hybrid | 0.0 |
| Cell Reports | 204 (160–274) | 1,534 | 22 | $5,790 | Open access (DOAJ) | 0.0 |
| Cancer Cell | 206 (31–307) | 203 | 23 | ≈$10,400 | Hybrid | 0.0 |
| Bone Research | 208 (176–260) | 99 | 72 | $3,525 | Open access (DOAJ) | 2.98 |
| Molecular Cancer Therapeutics | 209 (157–271) | 174 | — | — | Hybrid | 0.0 |
| Cell Reports Methods | 210 (148–274) | 178 | 26 | $4,970 | Open access (DOAJ) | 0.0 |
| The Journal of Cell Biology | 212 (157–280) | 232 | 35 | — | Hybrid | 0.0 |
| Molecular Biomedicine | 212 (142–278) | 140 | 20 | $2,990 | Open access (DOAJ) | 0.0 |
| npj Regenerative Medicine | 214 (128–265) | 63 | 24 | $4,390 | Open access (DOAJ) | 0.0 |
| Genome Medicine | 215 (167–294) | 164 | 24 | $5,490 | Open access (DOAJ) | 0.0 |
| Communications Biology | 217 (165–292) | 1,969 | 16 | $4,390 | Open access (DOAJ) | 0.4 |
| Cell Metabolism | 223 (150–341) | 163 | 28 | ≈$10,400 | — | 0.0 |
| Molecular Cell | 224 (105–323) | 331 | 24 | ≈$10,400 | Hybrid | 0.62 |
| Cell Death and Differentiation | 225 (180–282) | 192 | 12 | ≈$5,790 | Hybrid | 0.0 |
| Nature Protocols | 232 (192–309) | 171 | 73 | — | — | 0.0 |
| Genome Research | 234 (181–309) | 207 | 62 | — | Hybrid | 0.0 |
| eLife | 235 (133–409) | 87 | 15 | $3,750 | Open access (DOAJ) | 0.0 |
| BioMed Research International | 239 (155–320) | 205 | 35 | ≈$2,680 | — | 165.35 |
| Nature Communications | 242 (178–329) | 12,015 | 19 | $7,350 | Open access (DOAJ) | 0.27 |
| Nature Structural & Molecular Biology | 243 (187–357) | 163 | 40 | ≈$12,690 | Hybrid | 0.0 |
| Nature Computational Science | 244 (195–296) | 100 | 42 | ≈$12,690 | Hybrid | 0.0 |
| Nature Plants | 246 (174–333) | 176 | 39 | ≈$12,690 | Hybrid | 0.0 |
| MedComm | 256 (201–331) | 464 | 37 | $3,850 | Open access (DOAJ) | 0.0 |
| Cell stem cell | 266 (131–346) | 119 | 25 | ≈$10,400 | Hybrid | 0.0 |
| Nature Biotechnology | 275 (189–394) | 141 | 42 | ≈$12,690 | Hybrid | 0.0 |
| Nature Microbiology | 279 (205–386) | 223 | 42 | ≈$12,690 | Hybrid | 0.0 |
| Developmental Cell | 280 (102–385) | 205 | 24 | ≈$10,400 | Hybrid | 0.0 |
| Cell | 287 (185–399) | 478 | 27 | ≈$11,400 | Hybrid | 0.48 |
| Genome biology | 288 (211–384) | 434 | 18 | $5,690 | Open access (DOAJ) | 0.0 |
| Cell Systems | 312 (221–410) | 138 | 27 | ≈$9,350 | Hybrid | 0.0 |
| Nature Cardiovascular Research | 316 (233–432) | 86 | 41 | ≈$12,690 | Hybrid | 0.0 |
| Nature Chemical Biology | 322 (233–396) | 173 | 39 | ≈$12,690 | Hybrid | 0.0 |
| Nature Cell Biology | 335 (245–416) | 151 | 47 | ≈$12,690 | Hybrid | 2.11 |
| Nature Methods | 338 (260–417) | 209 | 47 | ≈$12,690 | Hybrid | 0.68 |
| Genomics Proteomics & Bioinformatics | 350 (204–448) | 142 | — | $3,650 | Open access (DOAJ) | 0.0 |
| Nature Genetics | 390 (287–509) | 260 | 42 | ≈$12,690 | Hybrid | 0.0 |
| Nature Biomedical Engineering | 482 (384–588) | 202 | 48 | ≈$12,690 | — | 0.0 |
Journals are listed where at least 25% of their articles' topics fall in Molecular Biology (OpenAlex).
Latest available year: 2024
23 journals without enough usable 2025 data. Their 2024 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Biophysics Reports | 43 (27–74) | 59 | — | No fee (DOAJ) | Open access (DOAJ) | — |
| Biomolecular NMR Assignments | 50 (36–82) | 51 | 12 | ≈$3,890 | Hybrid | 0.0 |
| Biophysics and Physicobiology | 60 (37–92) | 55 | 2 | ≈$258 | Open access (DOAJ) | 0.0 |
| Current Opinion in Chemical Biology | 68 (46–103) | 92 | 23 | ≈$4,510 | Hybrid | 0.0 |
| Essays in Biochemistry | 71 (54–90) | 50 | — | — | — | 0.0 |
| Cell Stress and Chaperones | 72 (35–98) | 54 | 3 | $2,850 | Open access (DOAJ) | 10.53 |
| Plant Biotechnology | 76 (51–108) | 56 | — | — | Open access | 0.0 |
| Angiogenesis | 90 (68–141) | 51 | 21 | ≈$5,490 | Hybrid | 0.0 |
| Biochimica et Biophysica Acta (BBA) - Bioenergetics | 94 (64–144) | 67 | 4 | ≈$4,680 | — | 0.0 |
| Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics | 100 (80–132) | 152 | 156 | — | — | 0.0 |
| European Journal of Protistology | 101 (67–135) | 50 | 2 | ≈$3,270 | — | 0.0 |
| Chinese Journal of Natural Medicines | 103 (84–119) | 80 | — | ≈$3,000 | — | 0.0 |
| Amino Acids | 106 (71–159) | 59 | 21 | $3,690 | Open access (DOAJ) | 0.0 |
| Journal of Cellular Biochemistry | 108 (78–149) | 99 | 16 | ≈$5,110 | — | 1.77 |
| Transgenic Research | 112 (77–225) | 51 | 26 | ≈$3,990 | Hybrid | 0.0 |
| European Journal of Cell Biology | 123 (97–165) | 75 | 3 | $3,010 | Open access (DOAJ) | 0.0 |
| Neoplasma | 125 (77–173) | 51 | — | — | — | 0.0 |
| Molecular Informatics | 133 (92–152) | 51 | — | ≈$3,800 | — | 0.0 |
| Phenomics | 167 (124–223) | 57 | 197 | ≈$3,990 | — | — |
| Genes & Diseases | 171 (118–217) | 248 | 27 | $2,500 | Open access (DOAJ) | 0.0 |
| Chinese Herbal Medicines | 178 (125–250) | 56 | 4 | $1,200 | Open access (DOAJ) | 0.0 |
| Bioinformatics and Biology Insights | 209 (129–256) | 81 | 46 | $2,650 | Open access (DOAJ) | 0.0 |
| Biochemistry and Molecular Biology Education | 290 (242–381) | 60 | 13 | ≈$3,700 | — | 0.0 |
Latest available year: 2023
11 journals without enough usable 2025 data. Their 2023 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Genomics & Informatics | 83 (54–132) | 55 | 66 | $2,390 | Open access (DOAJ) | 0.0 |
| Journal of Molecular Recognition | 94 (57–129) | 57 | 18 | ≈$3,800 | — | 0.0 |
| Biological Chemistry | 100 (71–130) | 76 | 20 | — | Hybrid | 0.0 |
| Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms | 104 (78–147) | 67 | 6 | ≈$3,840 | — | 0.0 |
| Current Molecular Pharmacology | 106 (75–154) | 62 | — | — | — | 0.0 |
| Development Growth & Differentiation | 111 (59–173) | 54 | 23 | ≈$3,990 | — | 0.0 |
| Briefings in Functional Genomics | 111 (87–137) | 53 | — | ≈$3,700 | — | 0.0 |
| Yeast | 117 (77–164) | 50 | 17 | ≈$3,980 | Hybrid | — |
| Acta Biochimica Polonica | 125 (74–202) | 96 | — | $1,750 | Open access (DOAJ) | 2.57 |
| JBIC Journal of Biological Inorganic Chemistry | 126 (101–160) | 55 | 40 | ≈$3,990 | — | 0.0 |
| Cell Biochemistry and Biophysics | 145 (81–229) | 53 | 15 | ≈$3,990 | — | 2.1 |
Latest available year: 2022
12 journals without enough usable 2025 data. Their 2022 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Journal of Developmental Biology | 39 (31–53) | 51 | 5 | ≈$2,200 | Open access (DOAJ) | 0.0 |
| Oncotarget | 55 (42–98) | 60 | 16 | — | Open access | 0.0 |
| Life Medicine | 58 (34–81) | 54 | 4 | No fee (DOAJ) | Open access (DOAJ) | — |
| Frontiers in Genome Editing | 60 (39–93) | 58 | 23 | ≈$3,117 | Open access (DOAJ) | 0.0 |
| The Journal of Membrane Biology | 71 (47–95) | 57 | 24 | ≈$3,890 | — | — |
| European Journal of Histochemistry | 72 (47–111) | 52 | 20 | ≈$1,385 | Open access (DOAJ) | 0.0 |
| Emerging Topics in Life Sciences | 80 (55–100) | 57 | — | — | — | — |
| Wiley Interdisciplinary Reviews - RNA | 95 (73–154) | 58 | 27 | ≈$4,780 | — | 0.0 |
| Glycoconjugate Journal | 97 (70–132) | 52 | 21 | ≈$2,590 | Hybrid | 4.61 |
| Applied Biochemistry and Biotechnology | 119 (93–161) | 109 | 16 | ≈$3,890 | — | 3.13 |
| BMC Molecular and Cell Biology | 141 (112–184) | 56 | 14 | $2,590 | Open access (DOAJ) | 0.0 |
| Progress in Biophysics and Molecular Biology | 146 (88–192) | 60 | 5 | ≈$4,260 | — | 0.0 |
Latest available year: 2021
11 journals without enough usable 2025 data. Their 2021 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Current Genetics | 63 (32–93) | 74 | 19 | ≈$4,390 | — | — |
| Genes and Environment | 79 (58–112) | 58 | 20 | $2,590 | Open access (DOAJ) | — |
| Journal of Industrial Microbiology & Biotechnology | 82 (59–103) | 76 | — | $2,756 | Open access (DOAJ) | 0.0 |
| Biotechnology for Biofuels | 95 (66–139) | 218 | 13 | $2,990 | Open access (DOAJ) | 0.0 |
| Engineering in Life Sciences | 95 (73–131) | 72 | 23 | $3,630 | Open access (DOAJ) | 15.81 |
| Chemistry and Physics of Lipids | 103 (76–126) | 63 | 4 | ≈$3,870 | — | 0.0 |
| Journal of Bioenergetics and Biomembranes | 114 (82–141) | 55 | 14 | ≈$3,790 | — | 0.0 |
| Cells and Development | 115 (85–176) | 59 | 8 | ≈$3,450 | — | 0.0 |
| Journal of Pediatric Genetics | 126 (87–183) | 64 | 51 | — | — | — |
| Science Advances | 156 (115–208) | 1,022 | 47 | $5,450 | Open access (DOAJ) | 0.17 |
| Molecular vision | 269 (192–397) | 62 | 2 | No fee (DOAJ) | Open access (DOAJ) | 4.85 |
Latest available year: 2020
9 journals without enough usable 2025 data. Their 2020 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Cellular and Molecular Biology | 20 (10–141) | 183 | 31 | — | — | 0.0 |
| Journal of Bacteriology | 62 (40–110) | 191 | 62 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| Molecular and Cellular Biology | 85 (59–132) | 68 | 68 | — | — | 0.0 |
| Journal of Biomolecular NMR | 86 (73–105) | 52 | 14 | ≈$3,790 | — | — |
| Extremophiles | 93 (59–137) | 59 | 15 | ≈$2,590 | — | — |
| Current Genomics | 94 (71–128) | 66 | — | — | — | — |
| Environmental and Molecular Mutagenesis | 98 (63–132) | 54 | 21 | ≈$3,750 | — | 0.0 |
| Cytogenetic and Genome Research | 104 (81–150) | 56 | 86 | — | — | 0.0 |
| Acta Biochimica et Biophysica Sinica | 142 (83–179) | 60 | — | ≈$1,862 | Open access (DOAJ) | 0.95 |
Have a deadline?
Pick up to five journals and see whether a submission sequence can realistically reach acceptance before your defence, visa or job-market date. Free.
Open the submission plannerFrequently asked questions
Which Molecular Biology journals accepted papers fastest in 2025?
Among 389 Molecular Biology journals with enough dated articles in 2025, the shortest median time from submission to acceptance was 17 days (Doklady Biochemistry and Biophysics). The middle journal's median was 113 days. Speed is not a measure of quality; check scope, indexing and fees too.
How are these times measured?
From the submission and acceptance dates publishers deposit in PubMed, for accepted articles only. Each journal needs at least 50 dated articles in the year shown, and a table headed with a year contains only that year's figures.
Get the free Journal Submission Go/No-Go Checklist
The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.
Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.